Atlas FDA

DEFLUX INJECTABLE GEL

FDA premarket approval P000029/S017 · decided 2008-03-28

Approval details

PMA number
P000029
Supplement
S017
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
DEFLUX INJECTABLE GEL
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2006-03-06
Decision date
2008-03-28
Days to decision
753 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
APPROVAL FOR A MANUFACTURING SITE LOCATED AT Q-MED AB, UPPSALA, SWEDEN, TO TEST FOR HEAVY METALS AND ANALYSIS OF NITRATES.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26